Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-20

FDA Approved: LEVALBUTEROL — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Mylan's generic Levalbuterol for treatment or prevention of bronchospasm associated with reversible obstructive airway disease, including asthma an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levalbuterol (Levalbuterol)

Snippet

ORIG AP for LEVALBUTEROL (LEVALBUTEROL)